(S (NP-SBJ (NP (DT The) (NN promoter)) (PP (IN of) (NP (DT the) (NN CD19) (NN gene)))) (VP (VBZ is) (NP-PRD (NP (DT a) (NN target)) (PP (IN for) (NP (DT the) (JJ B-cell-specific) (NN transcription) (NN factor) (NN BSAP))))) (. .))
(S (NP-SBJ-26 (DT The) (NN CD19) (NN protein)) (VP-COOD (VP (VBZ is) (VP (VBN expressed) (NP (-NONE- *-26)) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (DT all) (JJ B-lymphoid) (NNS cells))))) (PP (IN with) (NP (NP (DT the) (NN exception)) (PP (IN of) (NP (ADJP (RB terminally) (VBN differentiated)) (NN plasma) (NNS cells))))))) (CC and) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (NP (-NONE- *-26)) (PP (IN as) (NP (DT a) (JJ signal-transducing) (NN receptor))) (PP (IN in) (NP (NP (DT the) (NN control)) (PP (IN of) (NP-COOD (NP (NN proliferation)) (CC and) (NP (NN differentiation)))))))))) (. .))
(S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP demonstrate) (NP (NP (JJ complete) (NN correlation)) (PP (IN between) (NP-COOD (NP (NP (DT the) (NN expression) (NN pattern)) (PP (IN of) (NP (DT the) (NN CD19) (NN gene)))) (CC and) (NP (NP (DT the) (JJ B-cell-specific) (NN transcription) (NN factor) (NN BSAP)) (PP (IN in) (NP (NP (DT a) (JJ large) (NN panel)) (PP (IN of) (NP (JJ B-lymphoid) (NN cell) (NNS lines)))))))))) (. .))
(S-COOD (S (NP-SBJ-28 (DT The) (JJ human) (NN CD19) (NN gene)) (VP (VBZ has) (VP (VBN been) (VP (VBN cloned) (NP (-NONE- *-28)))))) (, ,) (CC and) (S (NP-SBJ-29 (JJ several) (JJ BSAP-binding) (NNS sites)) (VP (VBP have) (VP (VBN been) (VP (VBN mapped) (NP (-NONE- *-29)) (PP (IN by) (NP (ADJP (FW in) (FW vitro)) (JJ protein-DNA) (NN binding) (NNS studies))))))) (. .))
(S (PP (IN In) (NP (JJ particular))) (, ,) (NP-SBJ-COOD (NP (DT a) (JJ high-affinity) (JJ BSAP-binding) (NN site)) (CONJP (RB instead) (IN of)) (NP (DT a) (NN TATA) (NN sequence))) (VP (VBZ is) (ADJP-PRD (JJ located) (PP (IN in) (NP (NP (DT the) (CD -30) (NN promoter) (NN region)) (ADJP (JJ upstream) (PP (IN of) (NP (NP (DT a) (NN cluster)) (PP (IN of) (NP (JJ heterogeneous) (NN transcription) (NN start) (NNS sites)))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP-SBJ-31 (DT this) (NN site)) (VP (VBZ is) (VP (VBN occupied) (NP (-NONE- *-31)) (PP (IN by) (NP-LGS (NP (NN BSAP)) (ADVP (FW in) (FW vivo)))) (PP-COOD (PP (IN in) (NP (DT a) (JJ CD19-expressing) (NN B-cell) (NN line))) (CC but) (PP (RB not) (IN in) (NP (NP-COOD (NP (NN plasma)) (CC or) (NP (NN HeLa))) (NNS cells)))))) (. .))
(S (NP-SBJ-32 (DT This) (JJ high-affinity) (NN site)) (VP-COOD (VP (VBZ has) (VP (VBN been) (VP (VBN conserved) (NP (-NONE- *-32)) (PP (IN in) (NP (NP (DT the) (NNS promoters)) (PP (IN of) (NP (UCP-COOD (CC both) (ADJP (JJ human)) (CC and) (NP (NN mouse))) (NN CD19) (NNS genes)))))))) (CC and) (VP (VBD was) (ADVP (RB furthermore)) (VP (VBN shown) (S (NP-SBJ (-NONE- *-32)) (VP (TO to) (VP (VB confer) (NP (NN B-cell) (NN specificity)) (PP (TO to) (NP (DT a) (NN beta-globin) (NN reporter) (NN gene))) (PP (IN in) (NP (JJ transient) (NN transfection) (NNS experiments))))))))) (. .))
(S (PP (IN In) (NP (NN addition))) (, ,) (NP-SBJ-34 (NN BSAP)) (VP (VBD was) (VP (VBN found) (S (NP-SBJ (-NONE- *-34)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT the) (RB only) (JJ abundant) (JJ DNA-binding) (NN activity)) (PP (IN of) (NP (NN B-cell) (JJ nuclear) (NNS extracts))) (SBAR (WHNP-35 (WDT that)) (S (NP-SBJ (-NONE- *T*-35)) (VP (VBZ interacts) (PP (IN with) (NP (DT the) (NN CD19) (NN promoter)))))))))))) (. .))
(S (ADVP (RB Together)) (, ,) (NP-SBJ (DT this) (NN evidence)) (ADVP (RB strongly)) (VP (VBZ implicates) (NP (NN BSAP)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (DT the) (NN CD19) (NN gene)))))) (. .))
